[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Glucosamine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

April 2018 | 137 pages | ID: G6CADB33F5E0EN
MIReports Co., Limited

US$ 3,680.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Glucosamine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Glucosamine industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Glucosamine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Glucosamine worldwide and market share by regions, with company and product introduction, position in the Glucosamine market
Market status and development trend of Glucosamine by types and applications
Cost and profit status of Glucosamine, and marketing status
Market growth drivers and challenges

The report segments the global Glucosamine market as:

Global Glucosamine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Glucosamine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Extraction
Fermentation

Global Glucosamine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Food
Medicine
Feed
Cosmetic
Other

Global Glucosamine Market: Manufacturers Segment Analysis (Company and Product introduction, Glucosamine Sales Volume, Revenue, Price and Gross Margin):

CELLMARK
Cargill
AMPIL
Koyo Chemical
Osamine
MAHTANI CHITOSAN
Bio-gen Extracts
Panvo Organics
Wanbury
Wellable Marine Biotech
Zhejiang Aoxing
Zhejiang Golden-Shell
Yangzhou Rixing Bio-Tech
Zhejiang Freemen Shinfuda
Taizhou Fengrun

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GLUCOSAMINE

1.1 Definition of Glucosamine in This Report
1.2 Commercial Types of Glucosamine
  1.2.1 Extraction
  1.2.2 Fermentation
1.3 Downstream Application of Glucosamine
  1.3.1 Food
  1.3.2 Medicine
  1.3.3 Feed
  1.3.4 Cosmetic
  1.3.5 Other
1.4 Development History of Glucosamine
1.5 Market Status and Trend of Glucosamine 2013-2023
  1.5.1 Global Glucosamine Market Status and Trend 2013-2023
  1.5.2 Regional Glucosamine Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Glucosamine 2013-2017
2.2 Sales Market of Glucosamine by Regions
  2.2.1 Sales Volume of Glucosamine by Regions
  2.2.2 Sales Value of Glucosamine by Regions
2.3 Production Market of Glucosamine by Regions
2.4 Global Market Forecast of Glucosamine 2018-2023
  2.4.1 Global Market Forecast of Glucosamine 2018-2023
  2.4.2 Market Forecast of Glucosamine by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Glucosamine by Types
3.2 Sales Value of Glucosamine by Types
3.3 Market Forecast of Glucosamine by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Glucosamine by Downstream Industry
4.2 Global Market Forecast of Glucosamine by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Glucosamine Market Status by Countries
  5.1.1 North America Glucosamine Sales by Countries (2013-2017)
  5.1.2 North America Glucosamine Revenue by Countries (2013-2017)
  5.1.3 United States Glucosamine Market Status (2013-2017)
  5.1.4 Canada Glucosamine Market Status (2013-2017)
  5.1.5 Mexico Glucosamine Market Status (2013-2017)
5.2 North America Glucosamine Market Status by Manufacturers
5.3 North America Glucosamine Market Status by Type (2013-2017)
  5.3.1 North America Glucosamine Sales by Type (2013-2017)
  5.3.2 North America Glucosamine Revenue by Type (2013-2017)
5.4 North America Glucosamine Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Glucosamine Market Status by Countries
  6.1.1 Europe Glucosamine Sales by Countries (2013-2017)
  6.1.2 Europe Glucosamine Revenue by Countries (2013-2017)
  6.1.3 Germany Glucosamine Market Status (2013-2017)
  6.1.4 UK Glucosamine Market Status (2013-2017)
  6.1.5 France Glucosamine Market Status (2013-2017)
  6.1.6 Italy Glucosamine Market Status (2013-2017)
  6.1.7 Russia Glucosamine Market Status (2013-2017)
  6.1.8 Spain Glucosamine Market Status (2013-2017)
  6.1.9 Benelux Glucosamine Market Status (2013-2017)
6.2 Europe Glucosamine Market Status by Manufacturers
6.3 Europe Glucosamine Market Status by Type (2013-2017)
  6.3.1 Europe Glucosamine Sales by Type (2013-2017)
  6.3.2 Europe Glucosamine Revenue by Type (2013-2017)
6.4 Europe Glucosamine Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Glucosamine Market Status by Countries
  7.1.1 Asia Pacific Glucosamine Sales by Countries (2013-2017)
  7.1.2 Asia Pacific Glucosamine Revenue by Countries (2013-2017)
  7.1.3 China Glucosamine Market Status (2013-2017)
  7.1.4 Japan Glucosamine Market Status (2013-2017)
  7.1.5 India Glucosamine Market Status (2013-2017)
  7.1.6 Southeast Asia Glucosamine Market Status (2013-2017)
  7.1.7 Australia Glucosamine Market Status (2013-2017)
7.2 Asia Pacific Glucosamine Market Status by Manufacturers
7.3 Asia Pacific Glucosamine Market Status by Type (2013-2017)
  7.3.1 Asia Pacific Glucosamine Sales by Type (2013-2017)
  7.3.2 Asia Pacific Glucosamine Revenue by Type (2013-2017)
7.4 Asia Pacific Glucosamine Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Glucosamine Market Status by Countries
  8.1.1 Latin America Glucosamine Sales by Countries (2013-2017)
  8.1.2 Latin America Glucosamine Revenue by Countries (2013-2017)
  8.1.3 Brazil Glucosamine Market Status (2013-2017)
  8.1.4 Argentina Glucosamine Market Status (2013-2017)
  8.1.5 Colombia Glucosamine Market Status (2013-2017)
8.2 Latin America Glucosamine Market Status by Manufacturers
8.3 Latin America Glucosamine Market Status by Type (2013-2017)
  8.3.1 Latin America Glucosamine Sales by Type (2013-2017)
  8.3.2 Latin America Glucosamine Revenue by Type (2013-2017)
8.4 Latin America Glucosamine Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Glucosamine Market Status by Countries
  9.1.1 Middle East and Africa Glucosamine Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa Glucosamine Revenue by Countries (2013-2017)
  9.1.3 Middle East Glucosamine Market Status (2013-2017)
  9.1.4 Africa Glucosamine Market Status (2013-2017)
9.2 Middle East and Africa Glucosamine Market Status by Manufacturers
9.3 Middle East and Africa Glucosamine Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa Glucosamine Sales by Type (2013-2017)
  9.3.2 Middle East and Africa Glucosamine Revenue by Type (2013-2017)
9.4 Middle East and Africa Glucosamine Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GLUCOSAMINE

10.1 Global Economy Situation and Trend Overview
10.2 Glucosamine Downstream Industry Situation and Trend Overview

CHAPTER 11 GLUCOSAMINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Glucosamine by Major Manufacturers
11.2 Production Value of Glucosamine by Major Manufacturers
11.3 Basic Information of Glucosamine by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Glucosamine Major Manufacturer
  11.3.2 Employees and Revenue Level of Glucosamine Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 GLUCOSAMINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 CELLMARK
  12.1.1 Company profile
  12.1.2 Representative Glucosamine Product
  12.1.3 Glucosamine Sales, Revenue, Price and Gross Margin of CELLMARK
12.2 Cargill
  12.2.1 Company profile
  12.2.2 Representative Glucosamine Product
  12.2.3 Glucosamine Sales, Revenue, Price and Gross Margin of Cargill
12.3 AMPIL
  12.3.1 Company profile
  12.3.2 Representative Glucosamine Product
  12.3.3 Glucosamine Sales, Revenue, Price and Gross Margin of AMPIL
12.4 Koyo Chemical
  12.4.1 Company profile
  12.4.2 Representative Glucosamine Product
  12.4.3 Glucosamine Sales, Revenue, Price and Gross Margin of Koyo Chemical
12.5 Osamine
  12.5.1 Company profile
  12.5.2 Representative Glucosamine Product
  12.5.3 Glucosamine Sales, Revenue, Price and Gross Margin of Osamine
12.6 MAHTANI CHITOSAN
  12.6.1 Company profile
  12.6.2 Representative Glucosamine Product
  12.6.3 Glucosamine Sales, Revenue, Price and Gross Margin of MAHTANI CHITOSAN
12.7 Bio-gen Extracts
  12.7.1 Company profile
  12.7.2 Representative Glucosamine Product
  12.7.3 Glucosamine Sales, Revenue, Price and Gross Margin of Bio-gen Extracts
12.8 Panvo Organics
  12.8.1 Company profile
  12.8.2 Representative Glucosamine Product
  12.8.3 Glucosamine Sales, Revenue, Price and Gross Margin of Panvo Organics
12.9 Wanbury
  12.9.1 Company profile
  12.9.2 Representative Glucosamine Product
  12.9.3 Glucosamine Sales, Revenue, Price and Gross Margin of Wanbury
12.10 Wellable Marine Biotech
  12.10.1 Company profile
  12.10.2 Representative Glucosamine Product
  12.10.3 Glucosamine Sales, Revenue, Price and Gross Margin of Wellable Marine Biotech
12.11 Zhejiang Aoxing
  12.11.1 Company profile
  12.11.2 Representative Glucosamine Product
  12.11.3 Glucosamine Sales, Revenue, Price and Gross Margin of Zhejiang Aoxing
12.12 Zhejiang Golden-Shell
  12.12.1 Company profile
  12.12.2 Representative Glucosamine Product
  12.12.3 Glucosamine Sales, Revenue, Price and Gross Margin of Zhejiang Golden-Shell
12.13 Yangzhou Rixing Bio-Tech
  12.13.1 Company profile
  12.13.2 Representative Glucosamine Product
  12.13.3 Glucosamine Sales, Revenue, Price and Gross Margin of Yangzhou Rixing Bio-Tech
12.14 Zhejiang Freemen Shinfuda
  12.14.1 Company profile
  12.14.2 Representative Glucosamine Product
  12.14.3 Glucosamine Sales, Revenue, Price and Gross Margin of Zhejiang Freemen Shinfuda
12.15 Taizhou Fengrun
  12.15.1 Company profile
  12.15.2 Representative Glucosamine Product
  12.15.3 Glucosamine Sales, Revenue, Price and Gross Margin of Taizhou Fengrun

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GLUCOSAMINE

13.1 Industry Chain of Glucosamine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GLUCOSAMINE

14.1 Cost Structure Analysis of Glucosamine
14.2 Raw Materials Cost Analysis of Glucosamine
14.3 Labor Cost Analysis of Glucosamine
14.4 Manufacturing Expenses Analysis of Glucosamine

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications